UNICYCIVE THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Other
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Adjustments to Additional Paid in Capital, Other of $1.09 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2026-03-30
- UNICYCIVE THERAPEUTICS, INC. adjustments to additional paid in capital, other for the quarter ending 2024-06-30 was $887.00K.
- UNICYCIVE THERAPEUTICS, INC. adjustments to additional paid in capital, other for the quarter ending 2024-03-31 was -$208.00K.
- UNICYCIVE THERAPEUTICS, INC. adjustments to additional paid in capital, other for fiscal 2024 was $1.09M.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 3 month as first filed | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 12 month | Adjustments to Additional Paid in Capital, Other 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $1.09M 10-K · filed 2026-03-30 | -$1.09M 10-K · filed 2025-03-31 | |||
| 2024-06-30 | $887.00K 10-Q · filed 2024-11-13 | $679.00K derived: sum of 2 quarters · filed 2025-05-14 | |||
| 2024-03-31 | -$208.00K 10-Q · filed 2025-05-14 | $208.00K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |